Skip to main content

Code Breakers

Mozilla Science Lab, a branch of the Internet nonprofit Mozilla, is running an experiment to see if review processes could up the quality of researcher-developed software, Erika Check Hayden reports this week at Nature News.

While many researchers develop and use software in their work, most have not received "formal training in coding best practice," Check Hayden writes.

This has led to a variety of issues, including some high-profile incidents — for instance, she notes, some have suggested that the fraudulent research of Duke University scientist Anil Potti "would have been exposed much earlier" had he "been compelled to publish his data and computer code along with his original papers."

Less scandalous, but perhaps even more alarming, Check Hayden writes, are the instances where researchers presumably operating in good faith are led astray by poor coding practice. She cites the example of Scripps researcher Geoffrey Chang, who in 2006 had to retract five papers on crystal structure "after finding a simple error in the code he was using."

In their experiment, the Mozilla researchers have subjected nine papers from PLOS Computational Biology to the sort of code review typically given to commercial software prior to release. A preliminary report on their findings is expected with the next few weeks.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.